• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫半胱氨酸蛋白酶恶性疟原虫蛋白酶-2和恶性疟原虫蛋白酶-3的底物特异性研究及其激肽原酶活性的证明。

Substrate specificity studies of the cysteine peptidases falcipain-2 and falcipain-3 from Plasmodium falciparum and demonstration of their kininogenase activity.

作者信息

Cotrin Simone S, Gouvêa Iuri E, Melo Pollyana M S, Bagnaresi Piero, Assis Diego M, Araújo Mariana S, Juliano Maria Aparecida, Gazarini Marcos L, Rosenthal Philip J, Juliano Luiz, Carmona Adriana K

机构信息

Departamento de Biofísica, Universidade Federal de São Paulo, Rua 3 de maio 100, 04044-020 São Paulo, SP, Brazil.

出版信息

Mol Biochem Parasitol. 2013 Feb;187(2):111-6. doi: 10.1016/j.molbiopara.2013.01.002. Epub 2013 Jan 24.

DOI:10.1016/j.molbiopara.2013.01.002
PMID:23354130
Abstract

We studied the substrate specificity requirements of recombinant cysteine peptidases from Plasmodium falciparum, falcipain-2 (FP-2) and falcipain-3 (FP-3), using fluorescence resonance energy transfer (FRET) peptides as substrates. Systematic modifications were introduced in the lead sequence Abz-KLRSSKQ-EDDnp (Abz=ortho-aminobenzoic acid; EDDnp=N-[2,4-dinitrophenyl]ethylenediamine) resulting in five series assayed to map S3-S'2 subsite specificity. Despite high sequence identity and structural similarity between FP-2 and FP-3, noteworthy differences in substrate specificity were observed. The S1 subsite of FP-2 preferentially accommodates peptides containing the positively charged residue Arg in P1, while FP-3 has a clear preference for the hydrophobic residue Leu in this position. The S2 subsite of FP-2 and FP-3 presents a strict specificity for hydrophobic residues, with Leu being the residue preferred by both enzymes. FP-2 did not show preference for the residues present at P3, while FP-3 hydrolysed the peptide Abz-ALRSSRQ-EDDnp, containing Ala at P3, with the highest catalytic efficiency of all series studied. FP-2 has high susceptibility for substrates containing hydrophobic residues in P'1, while FP-3 accommodates well peptides containing Arg in this position. The S'2 subsite of both enzymes demonstrated broad specificity. In addition, radioimmunoassay experiments indicated that kinins can be generated by FP-2 and FP-3 proteolysis of high molecular weight kininogen (HK). Both enzymes excised Met-Lys-bradykinin, Lys-bradykinin and bradykinin from the fluorogenic peptide Abz-MISLMKRPPGFSPFRSSRI-NH2, which corresponds to the Met(375) to Ile(393) sequence of HK. The capability of FP-2 and FP-3 to release kinins suggests the involvement of these enzymes in the modulation of malaria pathophysiology.

摘要

我们使用荧光共振能量转移(FRET)肽作为底物,研究了恶性疟原虫重组半胱氨酸肽酶——恶性疟原虫蛋白酶-2(FP-2)和恶性疟原虫蛋白酶-3(FP-3)的底物特异性要求。在先导序列Abz-KLRSSKQ-EDDnp(Abz = 邻氨基苯甲酸;EDDnp = N-[2,4-二硝基苯基]乙二胺)中引入了系统修饰,产生了五个系列用于测定,以绘制S3-S'2亚位点特异性图谱。尽管FP-2和FP-3之间具有高度的序列同一性和结构相似性,但观察到底物特异性存在显著差异。FP-2的S1亚位点优先容纳P1中含有带正电荷残基Arg的肽,而FP-3在该位置对疏水残基Leu有明显偏好。FP-2和FP-3的S2亚位点对疏水残基具有严格特异性,Leu是两种酶都偏好的残基。FP-2对P3处存在的残基没有偏好,而FP-3水解在P3处含有Ala的肽Abz-ALRSSRQ-EDDnp,在所研究的所有系列中催化效率最高。FP-2对P'1中含有疏水残基的底物具有高敏感性,而FP-3在该位置能很好地容纳含有Arg的肽。两种酶的S'2亚位点表现出广泛的特异性。此外,放射免疫分析实验表明,激肽可通过FP-2和FP-3对高分子量激肽原(HK)的蛋白水解产生。两种酶都从荧光肽Abz-MISLMKRPPGFSPFRSSRI-NH2中切除了甲硫氨酸-赖氨酸-缓激肽、赖氨酸-缓激肽和缓激肽,该荧光肽对应于HK的Met(375)至Ile(393)序列。FP-2和FP-3释放激肽的能力表明这些酶参与了疟疾病理生理学的调节。

相似文献

1
Substrate specificity studies of the cysteine peptidases falcipain-2 and falcipain-3 from Plasmodium falciparum and demonstration of their kininogenase activity.恶性疟原虫半胱氨酸蛋白酶恶性疟原虫蛋白酶-2和恶性疟原虫蛋白酶-3的底物特异性研究及其激肽原酶活性的证明。
Mol Biochem Parasitol. 2013 Feb;187(2):111-6. doi: 10.1016/j.molbiopara.2013.01.002. Epub 2013 Jan 24.
2
Differences in substrate and inhibitor sequence specificity of human, mouse and rat tissue kallikreins.人、小鼠和大鼠组织激肽释放酶在底物和抑制剂序列特异性上的差异。
Biochem J. 2004 Jun 15;380(Pt 3):775-81. doi: 10.1042/BJ20031047.
3
Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.组织激肽释放酶和T-激肽原酶的底物特异性:它们在激肽原加工中的可能作用。
Biochemistry. 1992 Jun 2;31(21):4969-74. doi: 10.1021/bi00136a008.
4
S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.重组人组织蛋白酶K的S3至S3'亚位点特异性及选择性内淬灭荧光底物的开发。
Biochem J. 2003 Aug 1;373(Pt 3):981-6. doi: 10.1042/BJ20030438.
5
S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.人血浆激肽释放酶和组织激肽释放酶1对源自人激肽原缓激肽结构域的肽进行水解时的S(1)'和S(2)'亚位点特异性
Biol Chem. 2008 Dec;389(12):1487-94. doi: 10.1515/BC.2008.166.
6
Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L.重组人组织蛋白酶V和组织蛋白酶L的比较底物特异性分析
Arch Biochem Biophys. 2004 Oct 15;430(2):274-83. doi: 10.1016/j.abb.2004.07.006.
7
Defining the substrate specificity of mouse cathepsin P.确定小鼠组织蛋白酶P的底物特异性。
Arch Biochem Biophys. 2005 Mar 1;435(1):190-6. doi: 10.1016/j.abb.2004.12.007.
8
Kininogen-derived fluorogenic substrates for investigating the vasoactive properties of rat tissue kallikreins--identification of a T-kinin-releasing rat kallikrein.用于研究大鼠组织激肽释放酶血管活性特性的激肽原衍生荧光底物——一种释放T激肽的大鼠激肽释放酶的鉴定
Eur J Biochem. 1997 Jul 15;247(2):652-8. doi: 10.1111/j.1432-1033.1997.00652.x.
9
Evaluation of the extent of the binding site in human tissue kallikrein by synthetic substrates with sequences of human kininogen fragments.用人激肽原片段序列的合成底物评估人组织激肽释放酶结合位点的范围。
Biochem J. 1995 Nov 15;312 ( Pt 1)(Pt 1):233-8. doi: 10.1042/bj3120233.
10
Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors.利用激肽释放酶抑制蛋白的反应中心环研究人组织激肽释放酶S'1和S'2亚位点的特异性:P'1和P'2位点在抑制剂设计中的重要性。
Biochem J. 2003 May 1;371(Pt 3):1021-5. doi: 10.1042/BJ20021952.

引用本文的文献

1
Human plasma kallikrein: roles in coagulation, fibrinolysis, inflammation pathways, and beyond.人血浆激肽释放酶:在凝血、纤维蛋白溶解、炎症途径及其他方面的作用。
Front Physiol. 2023 Aug 30;14:1188816. doi: 10.3389/fphys.2023.1188816. eCollection 2023.
2
Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?三十年靶向疟原虫裂殖体蛋白研发抗疟药物:我们从中得到了哪些启示,下一步该怎么做?
Curr Med Chem. 2024;31(16):2234-2263. doi: 10.2174/0929867331666230913165219.
3
Is there a role for bradykinin in cerebral malaria pathogenesis?
缓激肽在脑型疟疾发病机制中是否起作用?
Front Cell Infect Microbiol. 2023 Aug 10;13:1184896. doi: 10.3389/fcimb.2023.1184896. eCollection 2023.
4
Kinins and Their Receptors in Infectious Diseases.激肽及其受体在传染病中的作用
Pharmaceuticals (Basel). 2020 Aug 27;13(9):215. doi: 10.3390/ph13090215.
5
Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design.比较疟原虫 falcipains 和人同源物在前导肽和催化活性部位的序列和结构,用于基于肽的抗疟抑制剂设计。
Malar J. 2019 May 3;18(1):159. doi: 10.1186/s12936-019-2790-2.
6
Interaction of the Human Contact System with Pathogens-An Update.人类接触系统与病原体的相互作用——最新进展。
Front Immunol. 2018 Feb 26;9:312. doi: 10.3389/fimmu.2018.00312. eCollection 2018.